Topics
Glioblastoma | Treatment | Clinical trials | Immunosuppressive Drugs
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Immunosuppressive Drugs
Umemura Y, Clarke N, Al-Holou W, Elaimy A, Scott A, Leung D, Kim
M, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T,
Wahl D.
AB036. Targeting glioblastoma
de-novo purine metabolism to overcome chemoradiation resistance:
an interim result of phase 0/1 clinical trial in newly diagnosed
and recurrent glioblastoma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB036. doi:
10.21037/cco-24-ab036. PMID:
39295354. Interventional study. ˍ